PRODUCT FORMS

Dosage forms are essentially pharmaceutical products in the form in which they are marketed for use, typically involving a mixture of active drug components and non drug components (excipients). Depending on the method/route of administration, dosage forms come in several types. These include many kinds of liquid, solid, and semisolid dosage forms.

Of all the various pharmaceutical forms which currently exist, at Qilu Pharmaceutical we develop the following:

Injectables

Qilu Pharmaceutical has 15 different production lines for the manufacture of oncological and anti-infectious products as well as for cardiovascular, cerebrovascular and central nervous system pathologies. The annual production of lyophilized powder for injection is 100 million vials, 700 million vials of powder for injection and 400 million ampoules of small volume parenteral solutions.

Oral Solid Forms

Qilu Pharmaceutical has an annual capacity of 3.5 billion tablets and capsules, of various oncological and central nervous system products, as well as cephalosporin.

Drugs for external use

In Qilu Pharmaceutical manufacturing facilities we also make creams, eye ointments and sprays (with an output of over 34 million units per year).

Eye drops

Qilu Pharmaceutical production lines have advanced equipment for manufacturing eye drops with an annual production capacity of 100 million units.

Biosimilars

Qilu Pharmaceutical has launched in China biosimilars of rhG -CSF and rhIL- 11 and has many others to launch in the next 3-5 years.